Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma 14Leukemia 14Breast Neoplasms 9Lymphoma, Large B-Cell, Diffuse 7Osteosarcoma 5Gestational Trophoblastic Disease 4Central Nervous System Neoplasms 4Meningeal Carcinomatosis 3Lymphoma, Extranodal NK-T-Cell 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Oligodendroglioma 2Myelodysplastic Syndromes 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Leukemia, T-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2Choroid Plexus Neoplasms 2Burkitt Lymphoma 2Water Intoxication 1Thrombocythemia, Essential 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1

Interventions

Psychiatric Rehabilitation 2fludarabine phosphate 1carbendazim 1Therapeutics 1Rituximab 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Methotrexate 1Melphalan 1Levofloxacin 1Lenalidomide 1Ketamine 1Cyclosporine 1Ciprofloxacin 1Cefepime 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Intraocular Lymphoma × Methotrexate × Clear all
NCT03746223 2019-10-09

Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma

Peking Union Medical College Hospital

Phase 2 Unknown
42 enrolled
Lymphoid

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡